SCHEMBL19061464

SCHEMBL19061464

N#Cc1cccc(CSC2=NCN(Cc3cccnc3)CN2)c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GSK3A P49840 1/20 0.41
▸ GSK3B P49841 1/20 0.41
▸ DAO P14920 1/20 0.40
▸ HSD17B10 Q99714 2/20 0.40
▸ PKM P14618 1/20 0.40
▸ CTSB P07858 1/20 0.39
▸ MAPK1 P28482 3/20 0.39
▸ MEN1 O00255 2/20 0.39
▸ KMT2A Q03164 2/20 0.39
▸ CYP19A1 P11511 1/20 0.39
▸ CYP11B1 P15538 1/20 0.39
▸ CYP11B2 P19099 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ RAB9A P51151 1/20 0.39
▸ SMN1; SMN2 Q16637 1/20 0.39
▸ CHRNB2 P17787 1/20 0.39
▸ CHRNA4 P43681 1/20 0.39
▸ ALDH1A1 P00352 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP3A4 P08684 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19061875 0.84 ALDH1A1 (0.41) HSD17B10PKMMAPK1MEN1KMT2A
SCHEMBL19061885 0.84 MEN1 (0.52) HSD17B10PKMMAPK1MEN1KMT2A
SCHEMBL19061887 0.84 L3MBTL1 (0.51) DAOHSD17B10PKMMAPK1MEN1
SCHEMBL19061459 0.84 RAB9A (0.46) DAOHSD17B10PKMMAPK1MEN1
SCHEMBL19019917 0.84 TDP1 (0.46) HSD17B10PKMMAPK1MEN1KMT2A
SCHEMBL19019922 0.84 MAPK1 (0.50) HSD17B10PKMMAPK1MEN1KMT2A
SCHEMBL19019864 0.82 GFER (0.53) DAOHSD17B10PKMMEN1KMT2A
SCHEMBL19061599 0.82 KDM4E (0.53) DAOHSD17B10PKMRAB9AALDH1A1
SCHEMBL19061952 0.81 CYP1A2 (0.51) DAOHSD17B10PKMMAPK1MEN1
SCHEMBL19062037 0.81 METAP2 (0.43) HSD17B10PKMMAPK1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3184514-A1 AUTOPHAGY INHIBITORS Deutsches Krebsforschungszentrum (DE) 2017-06-28 — — EP disclosed
Send feedback